Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer.
作者信息
Guan Xiuwen, Ma Fei, Li Qiao, Chen Shanshan, Fan Ying, Wang Jiayu, Luo Yang, Zhang Pin, Li Qing, Xu Binghe
机构信息
Department of Medical Oncology and State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
Signal Transduct Target Ther. 2023 Mar 19;8(1):118. doi: 10.1038/s41392-023-01322-w.
Abstract
摘要
Zotero 插件